Inebilizumab
ATC L04AG10 · 7 markets · 7 records
Inebilizumab
Forms
US 1 records · 1 strengths
- 10 mginjectionUPLIZNA
CA 1 records · 1 strengths
- 10 mgliquidUPLIZNA
AU 1 records · 1 strengths
- 100 mginjectionUPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial
ES 1 records · 1 strengths
- 10 mg/1 mLinjectionUPLIZNA
TW 1 records · 1 strengths
- 100 mginjectionUPLIZNA for Intravenous Infusion 100 mg優視納點滴靜脈注射液100毫克
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名UPLIZNA ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 100 mg/10 mLinjectionUPLIZNA 100 mg, solution à diluer pour perfusion
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.